Cite Filings / CVKD / 0001628280-25-046441

Feed Companies Filings Check

Sign in

144

Sale of Securities

Cadrenal Therapeutics, Inc. Filed 2025-10-27 Acc 0001628280-25-046441

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-10-28 4 Chief Financial Officer sold 3,600 shares at $13.99 ($50,364)
2025-10-28 4 CEO and Chairman sold 2,444 shares at an average $14.01 ($34,237)
2025-10-27 144 Sale of Securities
2025-10-27 144 Sale of Securities
2025-10-24 144 Sale of Securities
2025-10-24 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…